Antibiotic Treatment for Enterococcus faecalis Wound Infection
Direct Recommendation
For this female patient with a wound infection (not urinary tract infection despite the "urine culture" label appearing to be a documentation error given the "Source: Wound" notation) caused by ampicillin-susceptible Enterococcus faecalis, prescribe ampicillin 2 grams IV every 6 hours for 7-14 days depending on clinical response and source control. 1
Rationale Based on Susceptibility Profile
Your culture shows the organism is susceptible to multiple agents with the following MICs:
- Ampicillin: ≤2 (Susceptible) - This is your first-line choice 1
- Penicillin: 8 (Susceptible)
- Vancomycin: 1 (Susceptible)
- Linezolid: 2 (Susceptible)
- Tigecycline: ≤0.12 (Susceptible)
Treatment Algorithm
First-Line Therapy (Recommended)
- Ampicillin 2 grams IV every 6 hours is the drug of choice for ampicillin-susceptible E. faecalis infections 1
- Duration: 7-14 days for soft tissue/wound infections depending on clinical improvement 1
- This can be transitioned to oral amoxicillin 500 mg three times daily once clinical improvement is documented and the patient can tolerate oral intake 1
Alternative Options (If Ampicillin Contraindicated)
If penicillin allergy:
- Vancomycin 15-20 mg/kg IV every 12 hours (target trough 10-15 mcg/mL) 2
- Duration: Same as ampicillin regimen
If concerns about IV access or transition to outpatient therapy:
- Linezolid 600 mg IV or PO every 12 hours 2, 3
- Advantage: Excellent oral bioavailability, no renal adjustment needed
- Critical monitoring requirement: Weekly complete blood counts due to risk of thrombocytopenia, anemia, and peripheral neuropathy with prolonged use 3
Important Clinical Considerations
Why NOT Other Agents
Gentamicin synergy is NOT needed for wound infections:
- The culture shows "Gentamicin High Level (Synergy): S, SYN-S" - this synergy testing is relevant only for endocarditis, not soft tissue infections 2
- Aminoglycosides should be avoided in routine wound infections due to nephrotoxicity risk without added benefit 2
Tigecycline should be avoided:
- Despite excellent susceptibility (MIC ≤0.12), tigecycline achieves low serum levels and should not be used for bacteremia or serious infections outside the abdomen 2
- Reserved for intra-abdominal infections involving VRE 2
Source Control is Critical
Failure to achieve adequate source control will lead to treatment failure regardless of antibiotic choice 3:
- Debride necrotic tissue if present
- Remove foreign bodies if applicable
- Drain any abscesses
- Consider wound care consultation for complex wounds
Common Pitfalls to Avoid
Do not underdose ampicillin:
- The full 2 grams every 6 hours (8 grams daily) is necessary for adequate tissue penetration in serious infections 1
- Lower doses may be appropriate only for uncomplicated urinary tract infections where high urinary concentrations are achieved 2
Do not assume this is a UTI:
- Despite the "urine culture" header, the specimen source is clearly documented as "WOUND" [@culture report]
- UTI treatment algorithms (nitrofurantoin, fosfomycin) do not apply here [@2@, 2, @13@]
Do not use cephalosporins:
- Enterococci have intrinsic resistance to cephalosporins despite what automated susceptibility systems may suggest [2, @5@]
Do not use fluoroquinolones:
- E. faecalis has high rates of fluoroquinolone resistance (46-58% in recent studies), making ciprofloxacin unreliable even if reported susceptible [@11@]
Monitoring During Therapy
- Clinical response: Improvement in wound appearance, decreased purulence, resolution of fever/leukocytosis within 48-72 hours
- If no improvement by 72 hours: Re-evaluate for source control issues, consider imaging for deeper infection, repeat cultures
- Transition to oral therapy: Once afebrile for 24-48 hours with clinical improvement, switch to amoxicillin 500 mg PO three times daily to complete course [@